Muazzam Khan is an expert in the development and manufacturing of biopharmaceuticals and serves as Head of Program Management at DiNAMIQS.
Dr. Khan has over a decade of biopharmaceutical experience and has served in process development and manufacturing roles at AstraZeneca, Lonza, Adaptimmune Therapeutics, and Celonic. At Adaptimmune, Dr. Khan served as the lead downstream process (DSP) scientist for early and late-stage process development of Adaptimmune’s advanced therapy medicinal products and was responsible for tech transfer for GMP manufacturing. At Celonic, he was a DSP team leader, supervising multiple early phase client projects.
Dr. Khan earned his MEng and EngD in Biochemical Engineering and Process Management from University College London.